Here, we discovered a synergistic effect of combined treatment with the FLT3 inhibitor Crenolanib and the Hedgehog pathway inhibitor HPI‐1 in the AML cell lines MOLM‐14 and MV4‐11. This evidence concerns the gene FLT3 and acute myeloid leukemia.